Empyemas secondary to ENT infections in children before, during and after the COVID-19 pandemic

IF 1.5 4区医学 Q4 CLINICAL NEUROLOGY

Neurochirurgie Pub Date : 2025-01-29 DOI:10.1016/j.neuchi.2025.101644

Anthony Joud, Fred Bteich, Irène Stella, Olivier Klein

{"title":"Empyemas secondary to ENT infections in children before, during and after the COVID-19 pandemic","authors":"Anthony Joud, Fred Bteich, Irène Stella, Olivier Klein","doi":"10.1016/j.neuchi.2025.101644","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>This study aims to analyze a series of cases admitted with intracranial empyema, either subdural or epidural, secondary to otorhinolaryngological (ENT) infections over a period of 10 years, including the COVID-19 pandemic. The incidence, characteristics, severity, and management of these conditions, as well as the influence of COVID-19, are described below.</div></div><div><h3>Methods</h3><div>The authors conducted a retrospective review of all of the children admitted to the Pediatric Neurosurgery Department of Nancy with intracranial empyemas secondary to a confirmed sinus (sinogenic) or mastoid (otogenic) infection between 2014 and 2024. They recorded their age, clinical presentation, initial Glasgow Coma Scale (GCS) score, bacteriological results, as well as the number and type of neurosurgical procedures they were subjected to, and their clinical outcome. These results were compared across two periods: before, and after the start of the COVID-19 pandemic.</div></div><div><h3>Results</h3><div>Nineteen children in total were surgically treated, with twelve having a subdural location for their empyema, and seven located exclusively in the epidural compartment. The clinical presentation and evolution were positive in all except for one epidural empyema (6/7), and in the majority of the subdural locations (10/12). Twelve patients (63,16%) were treated after the start of the COVID pandemic, including 11 between 2022 and 2023. No differences were observed in patient characteristics, bacterial population and prognosis between these two periods. No patient was proven positive for COVID-19 at the time of their treatment.</div></div><div><h3>Conclusions</h3><div>Empyemas secondary to ENT infections are potentially serious pathologies, whose prognosis has clearly improved over the years. The incidence has significantly increased during the COVID-19 pandemic, without changing the characteristics or prognosis of the pathology. This increase mainly took place in the last 2 years of the pandemic in our department. The incidence remains even higher than before 2020.</div></div>","PeriodicalId":51141,"journal":{"name":"Neurochirurgie","volume":"71 3","pages":"Article 101644"},"PeriodicalIF":1.5000,"publicationDate":"2025-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurochirurgie","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0028377025000177","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Objectives

This study aims to analyze a series of cases admitted with intracranial empyema, either subdural or epidural, secondary to otorhinolaryngological (ENT) infections over a period of 10 years, including the COVID-19 pandemic. The incidence, characteristics, severity, and management of these conditions, as well as the influence of COVID-19, are described below.

Methods

The authors conducted a retrospective review of all of the children admitted to the Pediatric Neurosurgery Department of Nancy with intracranial empyemas secondary to a confirmed sinus (sinogenic) or mastoid (otogenic) infection between 2014 and 2024. They recorded their age, clinical presentation, initial Glasgow Coma Scale (GCS) score, bacteriological results, as well as the number and type of neurosurgical procedures they were subjected to, and their clinical outcome. These results were compared across two periods: before, and after the start of the COVID-19 pandemic.

Results

Nineteen children in total were surgically treated, with twelve having a subdural location for their empyema, and seven located exclusively in the epidural compartment. The clinical presentation and evolution were positive in all except for one epidural empyema (6/7), and in the majority of the subdural locations (10/12). Twelve patients (63,16%) were treated after the start of the COVID pandemic, including 11 between 2022 and 2023. No differences were observed in patient characteristics, bacterial population and prognosis between these two periods. No patient was proven positive for COVID-19 at the time of their treatment.

Conclusions

Empyemas secondary to ENT infections are potentially serious pathologies, whose prognosis has clearly improved over the years. The incidence has significantly increased during the COVID-19 pandemic, without changing the characteristics or prognosis of the pathology. This increase mainly took place in the last 2 years of the pandemic in our department. The incidence remains even higher than before 2020.

查看原文本刊更多论文

在2019冠状病毒病大流行之前、期间和之后儿童耳鼻喉科感染继发的empemas。

目的：本研究旨在分析10年来包括COVID-19大流行在内的一系列耳鼻喉科（ENT）感染继发的硬膜下或硬膜外颅内脓肿病例。以下描述了这些疾病的发病率、特征、严重程度和管理，以及COVID-19的影响。方法：作者对2014年至2024年间在南希儿科神经外科收治的所有确诊为鼻窦（窦源性）或乳突（耳源性）感染的继发颅内脓肿的儿童进行了回顾性分析。他们记录了他们的年龄、临床表现、最初的格拉斯哥昏迷评分（GCS）评分、细菌学结果，以及他们接受的神经外科手术的次数和类型，以及他们的临床结果。这些结果在COVID-19大流行开始之前和之后两个时期进行了比较。结果：共有19例患儿接受手术治疗，其中12例为硬膜下脓肿，7例为硬膜外脓肿。除1例硬膜外脓肿（6/7）和大部分硬膜下部位（10/12）外，其余临床表现和发展均为阳性。12名患者（63.3%）在COVID大流行开始后接受了治疗，其中11名患者在2022年至2023年期间接受了治疗。这两个时期的患者特征、细菌数量和预后均无差异。在接受治疗时，没有患者被证实为COVID-19阳性。结论：耳鼻喉科感染继发脓胸是一种潜在的严重病理，近年来预后明显改善。在COVID-19大流行期间，发病率显着增加，但未改变病理特征或预后。这一增长主要发生在我省大流行的最后两年。发病率仍然高于2020年以前。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Neurochirurgie 医学-临床神经学

CiteScore

2.70

自引率

6.20%

发文量

100

审稿时长

29 days

期刊介绍： Neurochirurgie publishes articles on treatment, teaching and research, neurosurgery training and the professional aspects of our discipline, and also the history and progress of neurosurgery. It focuses on pathologies of the head, spine and central and peripheral nervous systems and their vascularization. All aspects of the specialty are dealt with: trauma, tumor, degenerative disease, infection, vascular pathology, and radiosurgery, and pediatrics. Transversal studies are also welcome: neuroanatomy, neurophysiology, neurology, neuropediatrics, psychiatry, neuropsychology, physical medicine and neurologic rehabilitation, neuro-anesthesia, neurologic intensive care, neuroradiology, functional exploration, neuropathology, neuro-ophthalmology, otoneurology, maxillofacial surgery, neuro-endocrinology and spine surgery. Technical and methodological aspects are also taken onboard: diagnostic and therapeutic techniques, methods for assessing results, epidemiology, surgical, interventional and radiological techniques, simulations and pathophysiological hypotheses, and educational tools. The editorial board may refuse submissions that fail to meet the journal''s aims and scope; such studies will not be peer-reviewed, and the editor in chief will promptly inform the corresponding author, so as not to delay submission to a more suitable journal. With a view to attracting an international audience of both readers and writers, Neurochirurgie especially welcomes articles in English, and gives priority to original studies. Other kinds of article - reviews, case reports, technical notes and meta-analyses - are equally published. Every year, a special edition is dedicated to the topic selected by the French Society of Neurosurgery for its annual report.